Nu Skin Buy Hold or Sell Recommendation

NUS -- USA Stock  

USD 63.79  0.37  0.58%

Considering 30-days investment horizon, and your above average risk tolerance our recommendation regarding Nu Skin Enterprises is 'Hold'. Macroaxis provides Nu Skin buy hold or sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding Nu Skin positions. The advice algorithm takes into account all of Nu Skin Enterprises available fundamental, technical, and predictive indicators you will find on this site. The advice is provided from Nu Skin buy-and-hold prospective. Please see also Nu Skin Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for muliple equity instruments please use Instant Ratings tool.

Time Horizon

Risk Tolerance

Execute Advice
Sell Nu SkinBuy Nu Skin

Hype Condition

Current Valuation

Odds of Distress

Economic Sensitivity

Analyst Consensus

Piotroski F Score

Financial Leverage

For the selected time horizon Nu Skin Enterprises has a risk adjusted performance of (0.05), jensen alpha of (0.07), total risk alpha of 0.1084, sortino ratio of 0.0 and treynor ratio of (0.24)
Macroaxis provides unbiased buy, hold, or sell suggestion on Nu Skin Enterprises that should be used to complement current analysts and expert consensus on Nu Skin. Our buy or sell recommendation engine determines the firm potential to grow exclusively from the prospective of investors current risk tolerance and investing horizon. To make sure Nu Skin Enterprises is not overpriced, please verify all Nu Skin Enterprises fundamentals including its Shares Owned by Institutions, Debt to Equity, Working Capital, as well as the relationship between Gross Profit and Price to Earnings To Growth . Given that Nu Skin Enterprises has Price to Earning of 22.77X, we recommend you check Nu Skin market performance and probability of bankruptcy to make sure the company can sustain itself next year given your latest risk tolerance and investing horizon.

Nu Skin Thematic Classifications

Wholesale IdeaWholesale
USA Equities from Wholesale industry as classified by Fama & French

Nu Skin Returns Distribution Density

Mean Return0.13Value At Risk4.09
Potential Upside2.57Standard Deviation2.74
 Return Density 

Institutional Investors

Security TypeSharesValue
Vanguard Group IncCommon Shares6.7 M553.5 M
Blackrock IncCommon Shares6.1 M500.1 M
Wellington Management Group LlpCommon Shares1.7 M138.3 M
Ajo LpCommon Shares1.5 M122.7 M
Aqr Capital Management LlcCommon Shares1.5 M120 M
State Street CorpCommon Shares1.4 M119.3 M
William Blair Investment Management LlcCommon Shares1.3 M104.1 M

Nu Skin Greeks

Alpha over DOW
Beta against DOW=0.57
Overall volatility
Information ratio =0.0082

Nu Skin Volatility Alert

Nu Skin Enterprises exhibits very low volatility with skewness of -2.99 and kurtosis of 13.51. However, we advise investors to further study Nu Skin Enterprises technical indicators to make sure all market info is available and is reliable.
 Better Than Average     
 Worse Than Average Compare Nu Skin to competition

Nu Skin Fundamental Vs Peers

FundamentalsNu SkinPeer Average
Return On Equity20.38% (15.17)%
Return On Asset12.20% (15.64)%
Profit Margin5.93% (5.50)%
Operating Margin15.15% (10.91)%
Current Valuation3.61B152.14B
Shares Outstanding55.55M1.43B
Shares Owned by Insiders2.51% 6.91%
Shares Owned by Institutions77.79% 18.37%
Number of Shares Shorted1.62M3.24M
Price to Earning22.77X40.69X
Price to Book4.27X14.44X
Price to Sales1.33X17.81X
Gross Profit1.78B21.75B
Net Income157.88M517.71M
Cash and Equivalents401.45M3.89B
Cash per Share7.23X5.17X
Total Debt448.22M7.36B
Debt to Equity53.80% 0.72%
Current Ratio1.93X3.30X
Book Value Per Share14.94X13.64X
Cash Flow from Operations208.72M1.25B
Short Ratio4.72X2.09X
Earnings Per Share2.80X2.30X
Price to Earnings To Growth2.14X1.22X
Number of Employees48.7K10.67K
Market Capitalization3.54B29.78B
Total Asset1.51B126.86B
Retained Earnings1.49B38.24B
Working Capital298.8M3.58B
Current Asset706.39M36.8B
   Exercise or conversion by D Dorny of 2500 shares of Nu Skin subject to Rule 16b-3 [view details]

Nu Skin Market Momentum

Nu Skin Alerts

Trading Alerts and Improvement Suggestions

Nu Skin Enterprises generates negative expected return over the last 30 days
Over 78.0% of the company shares are owned by institutional investors

Latest Analysts View

Nu Skin Current Analysts Recommendations

Target Median Price86.50
Target Mean Price82.00
Recommendation Mean2.10
Target High Price92.00
Number Of Analyst Opinions8
Target Low Price65.00
Please see also Nu Skin Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for muliple equity instruments please use Instant Ratings tool. Please also try Equity Search module to search for activelly-traded equities including funds and etfs from over 30 global markets.